INHIBITORY EFFECT OF VITAMIN-C ON THE MUTAGENICITY AND COVALENT DNA-BINDING OF THE ELECTROPHILIC AND CARCINOGENIC METABOLITE, 6-SULFOOXYMETHYLBENZO[A]PYRENE
Yj. Surh et al., INHIBITORY EFFECT OF VITAMIN-C ON THE MUTAGENICITY AND COVALENT DNA-BINDING OF THE ELECTROPHILIC AND CARCINOGENIC METABOLITE, 6-SULFOOXYMETHYLBENZO[A]PYRENE, Carcinogenesis, 15(5), 1994, pp. 917-920
6-Sulfooxymethylbenzo[a]pyrene has recently been shown to be a strong
hepatocarcinogen in infant male B6C3F(1) mice (Y.-J.Surh et al., Bioch
em. Biophys. Res. Commun., 172, 85-91, 1990) and appears to be an ulti
mate carcinogenic metabolite of 6-hydroxymethylbenzo[a] pyrene and pos
sibly of benzo[a]pyrene and 6-methylbenzo[a]pyrene. It produced high l
evels of aralkyl DNA adducts in the livers of B6C3F(1) mice and also e
xhibited strong direct mutagenicity toward Salmonella typhimurium TA98
without metabolic activation. In the present study we found that asco
rbic acid significantly reduced the bacterial mutagenicity and in vitr
o covalent DNA binding of 6-sulfooxymethylbenzo[a]pyrene. Ascorbic aci
d forms a mutagenically inactive covalent adduct with 6-sulfooxymethyl
benzo[a]pyrene, which appears to account for its novel protective mech
anism against this reactive sulfuric acid ester. It seems likely that
the formation of this adduct involves aralkylation of an ascorbic acid
anion by a presumed carbo cation derived from the electrophilic sulfu
ric acid ester.